Javascript must be enabled to continue!
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
View through CrossRef
AbstractFavipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of the current work is to develop the first validated green spectrophotometric methods for the determination of favipiravir and remdesivir in spiked human plasma. The UV absorption spectra of favipiravir and remdesivir have shown some overlap, making simultaneous determination difficult. Due to the considerable overlap, two ratio spectra manipulating spectrophotometric methods, namely, ratio difference and the first derivative of ratio spectra, enabled the determination of favipiravir and remdesivir in their pure forms and spiked plasma. The ratio spectra of favipiravir and remdesivir were derived by dividing the spectra of each drug by the suitable spectrum of another drug as a divisor to get the ratio spectra. Favipiravir was determined by calculating the difference between 222 and 256 nm of the derived ratio spectra, while calculating the difference between 247 and 271 nm of the derived ratio spectra enabled the determination of remdesivir. Moreover, the ratio spectra of every drug were transformed to the first order derivative using ∆λ = 4 and a scaling factor of 100. The first-order derivative amplitude values at 228 and 251.20 nm enabled the determination of favipiravir and remdesivir, respectively. Regarding the pharmacokinetic profile of favipiravir (Cmax 4.43 µg/mL) and remdesivir (Cmax 3027 ng/mL), the proposed methods have been successfully applied to the spectrophotometric determination of favipiravir and remdesivir in plasma matrix. Additionally, the greenness of the described methods was evaluated using three metrics systems: the national environmental method index, the analytical eco-scale, and the analytical greenness metric. The results demonstrated that the described models were in accordance with the environmental characteristics.
Springer Science and Business Media LLC
Title: Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
Description:
AbstractFavipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries.
The main objective of the current work is to develop the first validated green spectrophotometric methods for the determination of favipiravir and remdesivir in spiked human plasma.
The UV absorption spectra of favipiravir and remdesivir have shown some overlap, making simultaneous determination difficult.
Due to the considerable overlap, two ratio spectra manipulating spectrophotometric methods, namely, ratio difference and the first derivative of ratio spectra, enabled the determination of favipiravir and remdesivir in their pure forms and spiked plasma.
The ratio spectra of favipiravir and remdesivir were derived by dividing the spectra of each drug by the suitable spectrum of another drug as a divisor to get the ratio spectra.
Favipiravir was determined by calculating the difference between 222 and 256 nm of the derived ratio spectra, while calculating the difference between 247 and 271 nm of the derived ratio spectra enabled the determination of remdesivir.
Moreover, the ratio spectra of every drug were transformed to the first order derivative using ∆λ = 4 and a scaling factor of 100.
The first-order derivative amplitude values at 228 and 251.
20 nm enabled the determination of favipiravir and remdesivir, respectively.
Regarding the pharmacokinetic profile of favipiravir (Cmax 4.
43 µg/mL) and remdesivir (Cmax 3027 ng/mL), the proposed methods have been successfully applied to the spectrophotometric determination of favipiravir and remdesivir in plasma matrix.
Additionally, the greenness of the described methods was evaluated using three metrics systems: the national environmental method index, the analytical eco-scale, and the analytical greenness metric.
The results demonstrated that the described models were in accordance with the environmental characteristics.
Related Results
Effect of Remdesivir in COVID-19 in Terms of Hospital Discharge and Mortality Benefits
Effect of Remdesivir in COVID-19 in Terms of Hospital Discharge and Mortality Benefits
Background & Objective: There is no first line antiviral treatment for Corona Virus Disease 2019 (Covid-19). Remdesivir is used as antiviral drug for covid 19 in different part...
541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
Abstract
Background
Since the global outbreak of SARS-CoV-2, antiviral drugs have played a major role in the treatment of COVID-...
Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
(1) Background: Immune compromised hemodialysis patients are more likely to develop COVID-19 infections, which increase the risk of mortality. The benefits of Remdesivir, despite l...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Clinical Outcomes of COVID-19 Treated with Remdesivir Across the Continuum of Care
Clinical Outcomes of COVID-19 Treated with Remdesivir Across the Continuum of Care
Introduction: During the early phase of the coronavirus disease 2019
(COVID-19), remdesivir was only approved for hospitalized patients. Our
institution developed hospital-based, o...
Liver and Renal Injury with Remdesivir treatment in SARS-CoV-2 Patients
Liver and Renal Injury with Remdesivir treatment in SARS-CoV-2 Patients
Objective: To determine the effect of Remdesivir on liver enzymes and renal functions in SARS-CoV-2 patients.
Methods: This prospective cohort study was conducted at Dr. Ruth...
Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection
Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection
Abstract
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis in lower- and middle-income countries. HEV infection may lead to acute...
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
<p>Supplemental Figure 1. GPS and Physical Activity Data Overlaid on a. Greenness and b. Neighborhood Walkability. Supplemental Figure 2. Nonlinear Relationship between Activ...

